Mark H. Rozenbaum: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis

Rozenbaum, Mark H., Mangen, Marie-Josee J., Huijts, Susanne M., van der Werf, Tjip S., Postma, Maarten J.

Journal:

Year:

2015

Language:

english

File:

PDF, 979 KB

english, 2015

2

A review of the literature on the economics of vaccination against TB

Tu, Hong-Anh T, Vu, Hoa D, Rozenbaum, Mark H, Woerdenbag, Herman J, Postma, Maarten J

Journal:

Expert Review of Vaccines

Year:

2012

Language:

english

File:

PDF, 850 KB

english, 2012

3

The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review

Vondeling, Gerard T., Cao, Qi, Postma, Maarten J., Rozenbaum, Mark H.

Journal:

Applied Health Economics and Health Policy

Year:

2018

Language:

english

File:

PDF, 1.23 MB

english, 2018

4

Book reviews

Stolarik, M. Mark, Rozenbaum, Wlodzimierz, Matejko, Alexander, Lasky, Herbert

Journal:

Nationalities Papers

Year:

1977

Language:

english

File:

PDF, 686 KB

english, 1977

5

Cost–effectiveness of varicella vaccination programs: an update of the literature

Rozenbaum, Mark H, van Hoek, Albert Jan, Vegter, Stefan, Postma, Maarten J

Journal:

Expert Review of Vaccines

Year:

2008

Language:

english

File:

PDF, 482 KB

english, 2008

6

Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around…

Rozenbaum, Mark H, De Cao, Elisabetta, Westra, Tjalke A, Postma, Maarten J

Journal:

Expert Review of Vaccines

Year:

2012

Language:

english

File:

PDF, 1018 KB

english, 2012

7

1439. The Cost-Effectiveness of Vaccinating Adults at Increased Risk of Pneumococcal Disease Against Pneumococcal Disease in The Netherlands

Rozenbaum, Mark

Journal:

Open Forum Infectious Diseases

Year:

2018

Language:

english

File:

PDF, 334 KB

english, 2018

8

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world

Maarten J Postma, Mark Jit, Mark H Rozenbaum, Baudouin Standaert, Hong-Anh Tu, Raymond CW Hutubessy

Journal:

Year:

2011

Language:

english

File:

PDF, 325 KB

english, 2011

9

Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar®)

Mark H. Rozenbaum, Albert Jan van Hoek, Eelko Hak, Maarten J. Postma

Journal:

Year:

2010

Language:

english

File:

PDF, 161 KB

english, 2010

10

803Direct Costs and Duration of Hospitalization of Patients Hospitalized with Community Acquired Pneumonia: a Nationwide Retrospective Claims Database Analysis

Rozenbaum, Mark, Moerman, Cees, Jonker, Marcel, Mangen, Marie-Josee, Postma, Maarten

Journal:

Open Forum Infectious Diseases

Year:

2014

Language:

english

File:

PDF, 33 KB

english, 2014

11

Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination

Rozenbaum, Mark H, Boersma, Cornelis, Postma, Maarten J, Hak, Eelko

Journal:

Expert Review of Vaccines

Year:

2011

Language:

english

File:

PDF, 803 KB

english, 2011

12

Health economics of rotavirus immunization in Vietnam: Potentials for favorable cost-effectiveness in developing countries

Hong-Anh T. Tu, Mark H. Rozenbaum, Peter C. Coyte, Shu Chuen Li, Herman J. Woerdenbag, Maarten J. Postma

Journal:

Year:

2012

Language:

english

File:

PDF, 570 KB

english, 2012

13

Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands

Wagenvoort, Gertjan H.J., Knol, Mirjam J., de Melker, Hester E., Vlaminckx, Bart J., van der Ende, Arie, Rozenbaum, Mark H., Sanders, Elisabeth A.M.

Journal:

Year:

2016

Language:

english

File:

PDF, 888 KB

english, 2016

14

Estimating the Impact of Switching from a Lower to Higher Valent Pneumococcal Conjugate Vaccine in Colombia, Finland, and The Netherlands: A Cost-Effectiveness Analysis

Pugh, Sarah, Wasserman, Matt, Moffatt, Margaret, Marques, Susana, Reyes, Juan Manuel, Prieto, Victor A., Reijnders, Davy, Rozenbaum, Mark H., Laine, Juha, Ãhman, Heidi, Farkouh, Raymond

Journal:

Infectious Diseases and Therapy

Year:

2020

Language:

english

File:

PDF, 835 KB

english, 2020

15

Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands

Mark H. Rozenbaum, Eelko Hak, Tjip S. van der Werf, Maarten J. Postma

Journal:

Clinical Therapeutics

Year:

2010

Language:

english

File:

PDF, 313 KB

english, 2010

16

Response on “RE: Cost-effectiveness of pertussis booster vaccination in the Netherlands”

Rozenbaum, Mark H., Postma, Maarten J.

Journal:

Year:

2013

Language:

english

File:

PDF, 94 KB

english, 2013

17

An update of “Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model”

Hong Anh T Tu, Mark H Rozenbaum, Pieter T de Boer…

Journal:

BMC Infectious Diseases

Year:

2013

Language:

english

File:

PDF, 152 KB

english, 2013

18

Hearing Loss and Adenoidal Hypertrophy in an Adolescent with Nephropathic Cystinosis

Rozenbaum, Joseph A., Trachtman, Howard, Gloster, Elizabeth, Goldstein, Mark

Journal:

Otolaryngology - Head and Neck Surgery

Year:

1989

Language:

english

File:

PDF, 1.16 MB

english, 1989

19

On Discounting of Health Gains from Human Papillomavirus Vaccination: Effects of Different Approaches

Tjalke A. Westra, Mehraj Parouty, Werner B. Brouwer, Philippe H. Beutels, Raina M. Rogoza, Mark H. Rozenbaum, Toos Daemen, Jan C. Wilschut, Cornelis Boersma, Maarten J. Postma

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 683 KB

english, 2012

20

Economic evaluations of rotavirus immunization for developing countries: a review of the literature

Tu, Hong-Anh T, Woerdenbag, Herman J, Kane, Sumit, Rozenbaum, Mark H, Li, Shu Chuen, Postma, Maarten J

Journal:

Expert Review of Vaccines

Year:

2011

Language:

english

File:

PDF, 752 KB

english, 2011

21

Book reviews

Stolarik, M. Mark, Onyshkevyeh, Larissa M. L., Klier, John D., Ezergailis, Andrew, Kowalewski, David, Heit, Siegfried E., Zinam, Oleg, Rozenbaum, Wlodzimierz, Elbert, E. Duane, Critikos, Peter John

Journal:

Nationalities Papers

Year:

1979

Language:

english

File:

PDF, 956 KB

english, 1979

22

Review of regulatory recommendations for orphan drug submissions in the netherlands and scotland: focus on the underlying pharmacoeconomic evaluations

Stefan Vegter, Mark H. Rozenbaum, Roelien Postema, Keith Tolley, Maarten J. Postma

Journal:

Clinical Therapeutics

Year:

2010

Language:

english

File:

PDF, 1.53 MB

english, 2010

23

Letter by Rozenbaum et al Regarding Article, âCost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathyâ

Rozenbaum, Mark H., Kemner, Jason, Parasuraman, Bhash

Journal:

Year:

2020

File:

PDF, 129 KB

2020

24

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model

Mark H Rozenbaum, Marie-Josee J Mangen, Carlo Giaquinto, Jan C Wilschut, Eelko Hak, Maarten J Postma, Consensus Group on Dutch Rotavirus Vaccination (CoRoVa-Group)

Journal:

BMC Public Health

Year:

2011

Language:

english

File:

PDF, 602 KB

english, 2011

25

Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands

Stevanović, Jelena, Pompen, Marjolein, Le, Hoa H., Rozenbaum, Mark H., Tieleman, Robert G., Postma, Maarten J., Ahrens, Ingo

Journal:

Year:

2014

Language:

english

File:

PDF, 627 KB

english, 2014

26

Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening Programmes

Stefan Vegter,Cornelis Boersma,Mark Rozenbaum,Bob Wilffert…

Journal:

PharmacoEconomics

Year:

2008

Language:

english

File:

PDF, 168 KB

english, 2008

27

Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines

Mark H Rozenbaum, Elisabeth A M Sanders, Albert Jan van Hoek, Angelique G S C Jansen, Arie van der Ende, Germie van den Dobbelsteen, Gerwin D Rodenburg, Eelko Hak and Maarten J Postma

Journal:

Year:

2010

Language:

english

File:

PDF, 320 KB

english, 2010

28

1434. Cost-Effectiveness of Sequencial Vaccination With the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23 Valent Polysaccharide Vaccine (PPV23) in The Netherlands

Rozenbaum, Mark

Journal:

Open Forum Infectious Diseases

Year:

2018

Language:

english

File:

PDF, 989 KB

english, 2018

29

Cost-effectiveness of pertussis booster vaccination in the Netherlands

Mark H. Rozenbaum, Elisabetta De Cao, Maarten J. Postma

Journal:

Year:

2012

Language:

english

File:

PDF, 429 KB

english, 2012

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски